Ubs Group Ag Logic Bio Therapeutics, Inc. Transaction History

Ubs Group Ag

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.29 - $0.67 $3,314 - $7,656	-11,428 Reduced 53.71%	9,848 $3,000
Q2 2022 Aug 10, 2022	BUY	$0.35 - $0.74 $7,446 - $15,744	21,276 New	21,276 $8,000
Q1 2022 May 16, 2022	SELL	$0.61 - $2.49 $4,612 - $18,826	-7,561 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.2 - $4.53 $120,850 - $248,841	-54,932 Reduced 87.9%	7,561 $17,000
Q3 2021 Nov 15, 2021	SELL	$3.85 - $5.09 $10,013 - $13,239	-2,601 Reduced 4.0%	62,493 $286,000
Q2 2021 Aug 13, 2021	BUY	$4.03 - $7.57 $246,849 - $463,685	61,253 Added 1594.71%	65,094 $289,000
Q1 2021 May 12, 2021	BUY	$6.8 - $9.16 $5,208 - $7,016	766 Added 24.91%	3,841 $28,000
Q4 2020 Feb 11, 2021	BUY	$5.29 - $9.1 $15,520 - $26,699	2,934 Added 2080.85%	3,075 $23,000
Q3 2020 Nov 12, 2020	SELL	$5.41 - $9.45 $20,217 - $35,314	-3,737 Reduced 96.36%	141 $1,000
Q2 2020 Jul 31, 2020	SELL	$4.25 - $8.46 $4,118 - $8,197	-969 Reduced 19.99%	3,878 $33,000
Q1 2020 May 01, 2020	SELL	$4.06 - $11.0 $22,273 - $60,346	-5,486 Reduced 53.09%	4,847 $24,000
Q4 2019 Feb 14, 2020	BUY	$7.01 - $11.01 $27,990 - $43,962	3,993 Added 62.98%	10,333 $74,000
Q3 2019 Nov 14, 2019	BUY	$6.97 - $13.46 $33,727 - $65,132	4,839 Added 322.39%	6,340 $69,000
Q2 2019 Aug 14, 2019	BUY	$9.77 - $17.08 $14,205 - $24,834	1,454 Added 3093.62%	1,501 $20,000
Q1 2019 May 14, 2019	SELL	$7.93 - $10.41 $23,441 - $30,771	-2,956 Reduced 98.43%	47 $0
Q4 2018 Feb 14, 2019	BUY	$7.88 - $17.98 $23,663 - $53,993	3,003 New	3,003 $31,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.